Cargando…
Individual donation nucleic acid technology testing to minimize human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus transfusion transmitted infections
Autores principales: | Shyamala, Venkatakrishna, Sandison, Taylor G., Holmberg, Jerry A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943159/ https://www.ncbi.nlm.nih.gov/pubmed/24678186 http://dx.doi.org/10.4103/0973-6247.126708 |
Ejemplares similares
-
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
por: Shyamala, Venkatakrishna
Publicado: (2014) -
The Risk of Transfusion-Transmitted Hepatitis E Virus: Evidence from Seroprevalence Screening of Blood Donations
por: Wong, Li Ping, et al.
Publicado: (2021) -
Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010
por: Kim, Moon Jung, et al.
Publicado: (2012) -
Transfusion-Transmitted Hepatitis A Virus, France, 2018
por: Lefeuvre, Caroline, et al.
Publicado: (2022) -
Reducing the risk of hepatitis B virus transfusion-transmitted infection
por: Niederhauser, Christoph
Publicado: (2011)